Unibest
← Back to patent-cliff list

CAS 915087-25-1

4-amino-2-fluoro-N-methylbenzamide

Codes: ENZA-004, APAL-013

Application context (from source-drug indications)

Hormone-sensitive prostate cancerEnzalutamideCastration-resistant prostate cancerEnzalutamideProstate cancerEnzalutamideCastration-resistant prostate cancerApalutamideProstate cancerApalutamide

Source drugs (routes using this intermediate)

DrugTierExpiry
EnzalutamideTier A — Act now2027
ApalutamideTier A — Act now2030

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Qualified Partner — East China API Works5-Amino-3-(trifluoromethyl)picolinonitrile
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP SiteN-Boc-1-aminocyclobutanecarboxylic acid
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Site1-amino-N-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]Cyclobutanecarboxamide
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.